CADILA HEALTHCARE LTD. - Cadila Healthcare Ltd reply to clarification sought by the exchange

The Exchange had sought clarification from Cadila Healthcare Ltd with respect to news appearing in DNA on December 17, 2014 titled "Cadila's US Arm recalls 63,648 bottles of benzonatate capsules."<BR><BR>Cadila Healthcare Ltd replied stating "the recall by our US subsidiary was voluntary and a class-III type recall, which means that the use of the product is not likely to cause any adverse health consequences. There is no material impact."